Literature DB >> 15380670

Duality of innate stress responses in cardiac injury, repair, and remodeling.

Eric M Wilson1, Abhinav Diwan, Francis G Spinale, Douglas L Mann.   

Abstract

The ability of the myocardium to successfully adapt to cardiac injury ultimately determines whether the heart will decompensate and fail, or whether instead it will maintain preserved function. Despite the importance of the myocardial response to cardiac injury, very little is known with respect to the biochemical mechanisms that are responsible for mediating and integrating the stress response in the heart. In the present review we will summarize recent experimental material which suggests that the heart possess a germ-line encoded "innate" stress response that is activated in response to diverse forms of tissue injury. The extant literature suggests that this innate stress response plays an important role in initiating and integrating homeostatic responses within the heart. Nonetheless, as will be discussed further herein, these inflammatory mediators all have the potential to produce cardiac decompensation when expressed at sufficiently high concentrations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380670     DOI: 10.1016/j.yjmcc.2004.05.028

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  18 in total

1.  Monocyte-specific Bcl-2 expression attenuates inflammation and heart failure in monocyte chemoattractant protein-1 (MCP-1)-induced cardiomyopathy.

Authors:  Jianli Niu; Asim Azfer; Pappachan E Kolattukudy
Journal:  Cardiovasc Res       Date:  2006-03-16       Impact factor: 10.787

2.  Association of TNFSF8 polymorphisms with peripheral neutrophil count.

Authors:  Adelaide M Arruda-Olson; Véronique L Roger; High S Chai; Mariza de Andrade; Brooke L Fridley; Julie M Cunningham; Sherine E Gabriel; Suzette J Bielinski
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

Review 3.  TNF revisited: osteoprotegerin and TNF-related molecules in heart failure.

Authors:  Thor Ueland; Arne Yndestad; Christen P Dahl; Lars Gullestad; Pål Aukrust
Journal:  Curr Heart Fail Rep       Date:  2012-06

Review 4.  Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends?

Authors:  Melissa L Martin; Burns C Blaxall
Journal:  J Cardiovasc Transl Res       Date:  2012-09-27       Impact factor: 4.132

5.  Cardiac failure in C5-deficient A/J mice after Candida albicans infection.

Authors:  Alaka Mullick; Zully Leon; Gundula Min-Oo; Joanne Berghout; Rita Lo; Eugene Daniels; Philippe Gros
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

Review 6.  Role of inflammation in the progression of heart failure.

Authors:  Arne Yndestad; Jan Kristian Damås; Erik Øie; Thor Ueland; Lars Gullestad; Pål Aukrust
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

7.  Exercise does not increase cyclooxygenase-2 myocardial levels in young or senescent hearts.

Authors:  John C Quindry; Joel French; Karyn L Hamilton; Youngil Lee; Josh Selsby; Scott Powers
Journal:  J Physiol Sci       Date:  2010-01-07       Impact factor: 2.781

8.  Cardiac-targeted expression of soluble fas attenuates doxorubicin-induced cardiotoxicity in mice.

Authors:  Jianli Niu; Asim Azfer; Kangkai Wang; Xihai Wang; Pappachan E Kolattukudy
Journal:  J Pharmacol Exp Ther       Date:  2008-12-09       Impact factor: 4.030

9.  β2-Adrenergic receptor-dependent chemokine receptor 2 expression regulates leukocyte recruitment to the heart following acute injury.

Authors:  Laurel A Grisanti; Christopher J Traynham; Ashley A Repas; Erhe Gao; Walter J Koch; Douglas G Tilley
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-12       Impact factor: 11.205

10.  Neutrophilia predicts death and heart failure after myocardial infarction: a community-based study.

Authors:  Adelaide M Arruda-Olson; Guy S Reeder; Malcolm R Bell; Susan A Weston; Véronique L Roger
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.